Recombinant Bordetella avium Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Bordetella avium Monofunctional Biosynthetic Peptidoglycan Transglycosylase (mtgA)

Recombinant Bordetella avium Monofunctional biosynthetic peptidoglycan transglycosylase, referred to here as mtgA, is a recombinant protein derived from the bacterium Bordetella avium. This enzyme is crucial for the synthesis of peptidoglycan, a key component of bacterial cell walls. The recombinant form of this enzyme is produced in various hosts such as Escherichia coli, yeast, baculovirus, or mammalian cells, primarily for research purposes .

Function and Importance of mtgA

mtgA is involved in the biosynthesis of peptidoglycan, which provides structural integrity to the bacterial cell wall. This enzyme catalyzes the formation of the glycosidic bonds between the sugar moieties of peptidoglycan, a process essential for bacterial growth and survival. Understanding the function of mtgA can provide insights into potential targets for antibacterial therapies, as disrupting peptidoglycan synthesis can inhibit bacterial growth .

Characteristics of Bordetella avium

Bordetella avium is a Gram-negative coccobacillus belonging to the phylum Proteobacteria. It is an obligate aerobe and is known for being fastidious to culture. This bacterium can infect humans and is part of a genus that includes well-known pathogens like B. pertussis, B. parapertussis, and B. bronchiseptica .

Research Findings and Applications

Research on mtgA from Bordetella avium is primarily focused on understanding its role in peptidoglycan synthesis and its potential as a target for developing new antimicrobial agents. The recombinant form of this enzyme is used in research settings to study bacterial cell wall assembly and to explore novel therapeutic strategies against bacterial infections.

Table: Characteristics of Recombinant Bordetella avium mtgA

CharacteristicsDescription
SourceE. coli, Yeast, Baculovirus, Mammalian Cells
TargetBordetella species
FunctionMonofunctional biosynthetic peptidoglycan transglycosylase
ApplicationsResearch into bacterial cell wall synthesis and antimicrobial targets
Purity and StorageTypically high purity; stored under conditions to maintain stability

Product Specs

Form
Supplied as a lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a guideline.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
Note: While the tag type is determined during production, we can prioritize the development of a specified tag type if provided.
Synonyms
mtgA; BAV3005; Biosynthetic peptidoglycan transglycosylase; Glycan polymerase; Peptidoglycan glycosyltransferase MtgA; PGT
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-240
Protein Length
full length protein
Species
Bordetella avium (strain 197N)
Target Names
mtgA
Target Protein Sequence
MAASRTRSWLRRTGGVLMALLCLFLIYELAMFSMVVWYAHRDPGSSAIMREEISRLRETD PKAQLSYTWVPYDRINVTLKRAVIASEDANFTEHDGVEWDAIRKAWAYNQNQQAQGRATI RGGSTITQQLAKNLFLSGSRSYLRKGQELILTYMIEHVMSKERILELYLNIAEWGVGIFG AEAAARHYYGISAANLNASQSARLAAMLPNPRYYDKHRSTRYLNSRTAILLRRMRMVDIP
Uniprot No.

Target Background

Function
Recombinant *Bordetella avium* Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA) is a peptidoglycan polymerase that catalyzes glycan chain elongation from lipid-linked precursors.
Database Links

KEGG: bav:BAV3005

STRING: 360910.BAV3005

Protein Families
Glycosyltransferase 51 family
Subcellular Location
Cell inner membrane; Single-pass membrane protein.

Q&A

What is the function of mtgA in Bordetella avium?

Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA) in Bordetella avium serves as a glycan polymerase, catalyzing the polymerization of peptidoglycan glycan strands during bacterial cell wall synthesis. The enzyme functions specifically by forming glycosidic bonds between N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) subunits to create the peptidoglycan backbone. This process is essential for maintaining bacterial cell wall integrity and structural stability. Unlike bifunctional penicillin-binding proteins (PBPs), mtgA performs only the transglycosylase function without peptide cross-linking activity, making it a specialized component in the peptidoglycan synthesis machinery .

To study mtgA function experimentally, researchers typically use radiolabeled or fluorescently-tagged lipid II substrates to monitor glycan strand formation in vitro. Complementary approaches include gene knockout studies followed by phenotypic analysis of cell morphology, growth rates, and susceptibility to osmotic stress or cell wall-targeting antibiotics. These methodologies help elucidate the specific contribution of mtgA to Bordetella avium cell wall biogenesis and bacterial survival.

How is recombinant mtgA protein expressed and purified?

Recombinant Bordetella avium mtgA is typically expressed as a His-tagged fusion protein in E. coli expression systems. The full-length protein (amino acids 1-240) contains the complete functional domains, including the catalytic domain and transmembrane segment . The expression process generally follows these methodological steps:

  • Clone the mtgA gene (BAV3005) into an expression vector with an N-terminal His-tag

  • Transform the construct into an appropriate E. coli strain (commonly BL21(DE3))

  • Induce protein expression using IPTG at optimal concentration and temperature

  • Harvest cells and lyse using appropriate buffer systems containing detergents to solubilize the membrane-associated protein

  • Purify using nickel affinity chromatography, exploiting the His-tag

  • Perform size exclusion chromatography for further purification if needed

The purified protein is typically stored as a lyophilized powder or in a Tris/PBS-based buffer with 6% trehalose at pH 8.0 to maintain stability . For long-term storage, adding glycerol to a final concentration of 50% and storing at -20°C/-80°C in aliquots is recommended to prevent repeated freeze-thaw cycles that could compromise enzyme activity.

What is the role of the transmembrane segment in mtgA function?

The transmembrane (TM) segment of mtgA plays multiple critical roles in enzyme function beyond simple membrane anchoring. Research indicates that full-length mtgA with its transmembrane segment demonstrates significantly higher enzymatic activity compared to truncated forms lacking this domain . The TM segment contributes to:

  • Proper orientation of the catalytic domain relative to the peptidoglycan synthesis machinery

  • Enhanced substrate accessibility by positioning the enzyme at the interface where lipid II substrates are presented

  • Potential interactions with other membrane-associated cell wall synthesis proteins

  • Influence on substrate specificity and binding affinity

Methodologically, comparing the activity of full-length versus truncated mtgA variants reveals that the TM segment "may play a role in substrate and moenomycin binding and in the GT reaction" . This phenomenon is consistent with observations in other peptidoglycan synthesis enzymes, such as PBP1b, where the TM segment similarly affects enzymatic activity. Research approaches to investigate this aspect include detergent solubilization studies, reconstitution in membrane mimetics (nanodiscs, liposomes), and site-directed mutagenesis of TM residues to identify specific functional contributions.

How can mtgA activity be measured in vitro?

Measuring mtgA transglycosylase activity in vitro requires specialized approaches due to the membrane-associated nature of both the enzyme and its lipid II substrate. Several methodological strategies can be employed:

  • Radiolabeled substrate assay: Using lipid II substrates containing 14C or 3H-labeled GlcNAc to monitor incorporation into glycan chains, followed by separation of products using paper chromatography or SDS-PAGE and detection by autoradiography or scintillation counting.

  • Fluorescence-based assays: Employing dansylated or fluorescently-labeled lipid II analogues that exhibit altered fluorescence properties upon polymerization, allowing real-time monitoring of transglycosylase activity.

  • HPLC analysis: Separating and quantifying reaction products using specialized columns that can resolve different-length glycan chains.

  • Mass spectrometry: Characterizing reaction products by their molecular weights to determine chain lengths and modifications.

  • Moenomycin displacement assays: Using the competitive binding of the natural product moenomycin, which inhibits transglycosylases by mimicking their reaction transition state.

MethodAdvantagesLimitationsDetection Sensitivity
Radiolabeled substrateDirect measurement of catalytic activityRequires radioactive handling facilitiesHigh (pmol range)
Fluorescence-basedReal-time kinetics, no radioactivityRequires specialized substrate synthesisModerate (nmol range)
HPLC analysisDetailed product characterizationLower throughputModerate (nmol range)
Mass spectrometryPrecise molecular characterizationExpensive equipment, lower throughputHigh (pmol range)
Moenomycin displacementSimple binding assayIndirect measurement of activityModerate (nmol range)

For optimal results, it's recommended to use detergent-solubilized full-length mtgA with its transmembrane segment intact, as truncated forms show reduced activity . The choice of detergent is critical, with mild non-ionic detergents like DDM or CHAPS often providing the best balance between protein stability and activity.

What experimental approaches are used to study mtgA substrate specificity?

Investigating mtgA substrate specificity requires sophisticated biochemical and analytical techniques to understand the enzyme's preference for natural and modified substrates. Methodological approaches include:

  • Structure-activity relationship (SAR) studies: Using chemically modified lipid II variants to systematically probe the structural requirements for substrate recognition, including alterations to the:

    • Lipid chain length and composition

    • MurNAc-peptide stem structures

    • Sugar moieties (NAG/NAM)

    • Phosphate linker region

  • Competitive substrate assays: Measuring the relative rates of incorporation when presenting multiple substrate variants simultaneously to assess preference.

  • Kinetic parameter determination: Calculating Km, Vmax, and kcat values for different substrates to quantify relative affinities and processing efficiencies.

  • Product analysis: Characterizing the glycan chains produced using different substrates to determine if substrate structure affects product length or pattern.

  • Cross-species substrate utilization: Testing whether mtgA can process lipid II from different bacterial species to understand evolutionary conservation of substrate recognition.

The transmembrane segment of mtgA has been shown to influence substrate interactions , suggesting that membrane composition and physical properties may also affect substrate specificity. This can be investigated using reconstitution in different lipid environments (varying in charge, fluidity, and composition) to observe effects on activity and substrate preference.

Results from these studies not only provide fundamental insights into mtgA biochemistry but also inform potential strategies for developing selective inhibitors that could target specific bacterial species while sparing others.

How can contradictions in experimental data about mtgA be analyzed and resolved?

When faced with contradictory experimental results regarding mtgA function or properties, researchers should employ a systematic approach to identify the source of discrepancies and resolve contradictions. This process involves:

  • Detailed experimental condition comparison: Create a comprehensive table documenting all relevant experimental parameters across studies, including:

    • Protein construct details (full-length vs. truncated, tag position, linker sequences)

    • Expression system and purification methods

    • Buffer composition, pH, and temperature conditions

    • Substrate preparation methods and purity

    • Detergent types and concentrations

    • Analytical methods and their sensitivity ranges

  • Independent verification with multiple methods: Employ orthogonal techniques to confirm key findings, reducing method-specific artifacts.

  • Biological context consideration: Analyze whether differences might reflect genuine biological variability rather than experimental error, such as strain-specific adaptations or regulatory mechanisms.

  • Statistical analysis of contradictions: Apply techniques similar to those described in search result , which discusses methods for detecting factual contradictions. This includes:

    • Scoring the degree of contradiction between findings (on a scale of 1-5)

    • Using natural language inference (NLI) models to identify specific contradicting atomic facts

    • Contextualizing contradictions within the broader experimental framework

  • Collaborative resolution: When possible, engage with authors of contradictory studies to jointly investigate discrepancies through shared protocols or materials.

A structured approach for analyzing contradictions should decompose complex experimental results into "atomic facts" that can be individually evaluated, similar to the approach described for detecting contradictions in narratives . This allows precise identification of where contradictions occur and facilitates targeted investigation of those specific aspects.

What controls should be included in experiments involving recombinant mtgA?

Robust experimental design for studies involving recombinant Bordetella avium mtgA requires comprehensive controls to ensure valid and interpretable results. Essential controls include:

  • Enzyme activity controls:

    • Positive control: Known active transglycosylase (e.g., E. coli PBP1b) with established activity profile

    • Negative control: Heat-inactivated mtgA protein to establish baseline measurements

    • Catalytic mutant: mtgA variant with mutations in catalytic residues to confirm specificity of observed activity

  • Protein quality controls:

    • SDS-PAGE analysis to confirm purity and molecular weight

    • Western blot using anti-His antibodies to verify integrity of the recombinant protein

    • Mass spectrometry to confirm protein identity and detect potential modifications

    • Circular dichroism to assess proper protein folding

  • Substrate controls:

    • Substrate-only reactions to monitor spontaneous reactions or degradation

    • Known substrate analogs with established reactivity profiles

    • Lipid II preparations from different sources to assess substrate source effects

  • Inhibition and specificity controls:

    • Moenomycin treatment as a specific transglycosylase inhibitor control

    • Buffer components without protein to rule out non-enzymatic catalysis

    • Detergent concentration series to determine optimal conditions

    • Metal chelators (EDTA/EGTA) to assess metal-dependence of activity

  • Transmembrane domain controls:

    • Comparison of full-length versus truncated mtgA to assess TM domain contribution

    • Different detergent types to evaluate solubilization effects on activity

    • Reconstitution in membrane mimetics versus detergent solubilization

These controls should be systematically incorporated into experimental designs and explicitly reported in publications to facilitate interpretation and reproducibility. The selection of specific controls should be tailored to the particular research question and methodological approach being employed.

How can site-directed mutagenesis be used to study mtgA function?

Site-directed mutagenesis represents a powerful approach for dissecting the structure-function relationships within Bordetella avium mtgA. A comprehensive mutagenesis strategy should target multiple functional domains and utilize the following methodological approach:

  • Target selection based on structural and sequence analysis:

    • Conserved catalytic residues identified through multiple sequence alignment across species

    • Residues predicted to interact with substrates based on homology models

    • Transmembrane domain residues that may influence enzyme positioning and activity

    • Interface residues potentially involved in protein-protein interactions

  • Systematic mutagenesis strategy:

    • Alanine scanning: Replacing selected residues with alanine to remove side chain functionality

    • Conservative substitutions: Replacing residues with biochemically similar amino acids to probe specific interactions

    • Non-conservative substitutions: Introducing dramatic changes to test functional hypotheses

    • Domain swapping: Replacing entire functional domains with corresponding regions from related enzymes

  • Functional characterization of mutants:

    • Expression and solubility analysis to identify potentially destabilizing mutations

    • Thermal stability assays to quantify effects on protein stability

    • In vitro transglycosylase activity assays to measure catalytic effects

    • Substrate binding assays to distinguish between effects on binding versus catalysis

    • Moenomycin sensitivity to probe changes in inhibitor binding site

  • Data analysis and interpretation:

    • Classification of mutations based on their effects: catalytic, binding, structural, or regulatory

    • Mapping mutation effects onto structural models to identify functional hotspots

    • Correlation analysis between conservation level and functional importance

Mutation TypeTarget ResiduesExpected OutcomeAnalysis Methods
Catalytic siteConserved active site residuesReduced/abolished catalytic activity with preserved foldingActivity assays, CD spectroscopy
Substrate bindingResidues in predicted binding pocketAltered substrate affinity (Km) with potential changes in specificityBinding assays, kinetic analysis
Transmembrane domainHydrophobic/interface residuesChanges in membrane association or orientation affecting activityMembrane association assays, activity in different detergents
Regulatory elementsPotential allosteric sitesModified response to regulatory factors or conditionsActivity under varying conditions

The knowledge gained through systematic mutagenesis can provide crucial insights into mtgA's catalytic mechanism, substrate specificity determinants, and potential targetable sites for antimicrobial development, while also clarifying the observed influences of the transmembrane domain on enzymatic function .

What considerations are important for designing mtgA inhibition studies?

Designing rigorous inhibition studies for Bordetella avium mtgA requires careful planning to ensure reliable, reproducible, and physiologically relevant results. Key methodological considerations include:

  • Inhibitor selection and characterization:

    • Natural product inhibitors (e.g., moenomycin) as positive controls

    • Synthetic analogs based on substrate or transition state mimicry

    • Fragment-based approaches to identify novel chemical scaffolds

    • Complete physicochemical characterization (solubility, stability in assay conditions)

  • Assay optimization for inhibition studies:

    • Enzyme concentration adjustment to appropriate levels for inhibition detection

    • Substrate concentration considerations relative to Km for different inhibition mechanisms

    • Time course establishment to ensure measurements in the linear range

    • Detection method sensitivity assessment for inhibition quantification

  • Inhibition mechanism characterization:

    • Steady-state kinetic analysis with varying substrate and inhibitor concentrations

    • Determination of inhibition type (competitive, non-competitive, uncompetitive, mixed)

    • Calculation of inhibition constants (Ki, IC50) under standardized conditions

    • Residence time measurements for time-dependent inhibitors

  • Consideration of the transmembrane domain:

    • Testing inhibition against both full-length and truncated mtgA to assess TM domain influence

    • Evaluation in different membrane environments to account for potential effects on inhibitor access

    • Investigation of membrane-targeting inhibitor components, given the importance of the TM segment

  • Selectivity profiling:

    • Testing against related transglycosylases to determine specificity

    • Counter-screening against other glycosyltransferase families

    • Assessment of activity against mtgA from different bacterial species

  • Translation to cellular systems:

    • Correlation between in vitro inhibition and antibacterial activity

    • Cell wall analysis in treated bacteria to confirm on-target effects

    • Resistance development studies to assess inhibitor robustness

Importantly, when designing inhibition experiments, researchers should account for the known impact of the transmembrane segment on substrate and inhibitor interactions . This may necessitate using membrane mimetic systems rather than simple aqueous buffers for more physiologically relevant inhibition assessments.

How should kinetic data for mtgA enzymatic activity be analyzed?

Analysis of kinetic data for Bordetella avium mtgA requires specialized approaches that account for the membrane-associated nature of both the enzyme and its lipid II substrate. A comprehensive kinetic analysis methodology includes:

  • Steady-state kinetic parameter determination:

    • Plotting initial reaction velocities against substrate concentrations

    • Fitting data to appropriate enzyme kinetic models:

      • Michaelis-Menten equation for simple kinetics

      • Hill equation when cooperativity is suspected

      • Specialized models for interfacial enzymes working on membrane surfaces

    • Extracting key parameters (Km, Vmax, kcat, kcat/Km) with statistical confidence intervals

    • Accounting for substrate depletion in membrane environments

  • Analysis challenges specific to transmembrane enzymes:

    • Correcting for detergent effects on substrate presentation and effective concentration

    • Accounting for substrate aggregation or micelle formation

    • Normalizing for active enzyme fraction, which may vary with preparation method

    • Consideration of the transmembrane domain's influence on activity parameters

  • Product analysis and processivity assessment:

    • Quantifying glycan chain length distribution using size exclusion chromatography or MS

    • Determining processivity index (average number of polymerization events per binding event)

    • Analyzing the kinetics of individual transglycosylation steps within processive synthesis

  • Data visualization and statistical analysis:

    • Using residual plots to assess goodness of fit and identify systematic deviations

    • Applying bootstrap or Monte Carlo methods to estimate parameter confidence intervals

    • Employing global fitting approaches for complex kinetic schemes

    • Comparing kinetic parameters across experimental conditions using appropriate statistical tests

When interpreting kinetic data, researchers should consider that full-length mtgA with its transmembrane segment demonstrates different kinetic properties compared to truncated versions , highlighting the importance of using appropriate protein constructs that best represent the physiological enzyme state.

What statistical approaches are recommended for analyzing mtgA experimental results?

  • Experimental design considerations:

    • Power analysis to determine appropriate sample sizes

    • Randomization strategies to minimize systematic errors

    • Blocking designs to account for batch effects in protein preparations

    • Full factorial or response surface designs for multi-parameter optimization

  • Data preprocessing and quality assessment:

    • Outlier detection and handling using statistical methods (Grubbs' test, Dixon's Q test)

    • Normality testing to determine appropriate parametric or non-parametric approaches

    • Variance homogeneity assessment (Levene's test, Bartlett's test)

    • Transformation strategies when distribution assumptions are violated

  • Comparative analysis methods:

    • Student's t-test or Welch's t-test for two-condition comparisons

    • ANOVA with appropriate post-hoc tests for multi-condition experiments

    • Non-parametric alternatives (Mann-Whitney U, Kruskal-Wallis) when assumptions are violated

    • Mixed-effects models for handling repeated measurements and nested designs

  • Specialized methods for enzyme kinetics:

    • Non-linear regression with appropriate weighting schemes

    • Global fitting approaches for complex kinetic mechanisms

    • Bootstrap or jackknife resampling for parameter uncertainty estimation

    • Akaike Information Criterion (AIC) or Bayesian Information Criterion (BIC) for model selection

  • Handling contradictions and inconsistencies:

    • Meta-analytical approaches for integrating data across experiments

    • Contradiction scoring methods as described in research on factual contradiction detection

    • Bayesian methods to incorporate prior knowledge and update beliefs based on new data

  • Reporting standards:

    • Complete disclosure of statistical methods, including software packages and versions

    • Reporting of effect sizes and confidence intervals, not just p-values

    • Clear distinction between exploratory and confirmatory analyses

    • Sharing of raw data and analysis code for reproducibility

When applying these statistical approaches, researchers should be particularly attentive to the impact of experimental conditions on mtgA activity, especially considering the demonstrated influence of the transmembrane domain on enzymatic function . This may require specialized statistical approaches that account for the added variability introduced by membrane-associated proteins and their reconstitution systems.

How can structural biology approaches enhance understanding of mtgA function?

Structural biology techniques provide powerful insights into the molecular mechanisms of Bordetella avium mtgA function. Methodological approaches and their applications include:

The implementation of these approaches should consider the demonstrated importance of the transmembrane segment to mtgA function . Structural biology studies should ideally include the full-length protein whenever possible, or explicitly acknowledge the limitations of using truncated constructs that may not fully recapitulate native functional properties.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.